This retrospective cohort study examined the initial experience of using EXALT Model D single-use duodenoscopes for endoscopic retrograde cholangiopancreatography (ERCP) in a pediatric population. The study included 28 patients undergoing the procedure at a single quaternary care center. The primary focus was on technical success and safety, with no comparator group included to assess relative performance against reusable devices.
Technical outcomes were favorable across the cohort. Biliary cannulation was successful in all 28 cases. Procedure complexity, assessed by ASGE grade, was grade 1 or 2 in the majority of patients. Stone extraction was performed in 27 cases, stent removal in 25 cases, and new stent placement in 3 cases.
Safety analysis identified adverse events in 4 patients, including abdominal pain (n=2), post-ERCP pancreatitis (n=1), and cholangitis (n=1). No serious adverse events were reported, and no procedures required conversion to reusable duodenoscopes. However, the study did not report long-term follow-up data or cost-benefit analysis.
Key limitations include the single-center retrospective design, small sample size, and lack of a control group. Data were limited for younger/smaller patients and higher ASGE grades (3 and 4). As an observational study, these results describe associations rather than causation. While single-use duodenoscopes may offer a promising alternative for reducing infection risk and simplifying maintenance, superiority cannot be established, and generalizability to complex procedures remains uncertain.
View Original Abstract ↓
BackgroundEndoscopic retrograde cholangiopancreatography (ERCP) is a key diagnostic and therapeutic tool for hepato-pancreato-biliary conditions. Although widely performed in adults, ERCP in pediatric populations is less common and poses unique challenges, particularly concerning infection control. Reusable duodenoscopes have been linked to patient-to-patient transmission of multidrug-resistant organisms (MDROs), leading to increased interest in single-use duodenoscopes. This study describes the initial experience using single-use duodenoscopes in ERCP at a single pediatric quaternary care center.MethodsA retrospective chart review was conducted on all patients who underwent ERCP with the EXALT™ Model D single-use duodenoscope at a single pediatric center from November 1, 2022, to April 15, 2025. Demographics, procedural details, ERCP complexity scores, and post-procedure complications were collected. Descriptive statistics were used for analysis.ResultsTwenty-eight patients (mean age 16 years; 64% female) underwent ERCP with a single-use duodenoscope. Biliary cannulation was successful in 100% of cases. Most procedures were ASGE grade 1 or 2. Stone extraction was performed in 27 cases, stent removal in 25, and new stent placement in 3. Complications occurred in 4 patients (14%): abdominal pain (n = 2), post-ERCP pancreatitis (n = 1), and cholangitis (n = 1), with no cases of post-procedure bleeding or MDRO infections. No procedures required conversion to reusable duodenoscopes.ConclusionsSingle-use duodenoscopes were effective and safe for ERCP in a pediatric cohort, achieving high technical success and low complication rates. While more studies are needed, particularly in younger or smaller patients and at higher ASGE grades (3 and 4), single-use duodenoscopes may offer a promising alternative to reusable devices, especially in reducing infection risk and simplifying scope maintenance. Broader adoption may depend on the development of pediatric-specific devices and cost-benefit analyses in varying clinical settings.